51. Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides
- Author
-
Constanza Cárdenas, Verónica Rojas, Fanny Guzmán, Luis Rivas, Fondo Nacional de Desarrollo Científico y Tecnológico (Chile), and Instituto de Salud Carlos III
- Subjects
Cyanobacteria ,Pharmaceutical Science ,Antineoplastic Agents ,Review ,01 natural sciences ,Bioactive compounds ,Analytical Chemistry ,lcsh:QD241-441 ,03 medical and health sciences ,lcsh:Organic chemistry ,Bacterial Proteins ,Drug Discovery ,Microalgae ,Animals ,Humans ,Physical and Theoretical Chemistry ,Antihypertensive Agents ,Solid-Phase Synthesis Techniques ,030304 developmental biology ,chemistry.chemical_classification ,Nostocales ,0303 health sciences ,biology ,010405 organic chemistry ,Organic Chemistry ,Algal Proteins ,Anti-Inflammatory Agents, Non-Steroidal ,Eukaryota ,Drug Synergism ,biology.organism_classification ,Cyclic peptide ,0104 chemical sciences ,Anti-Bacterial Agents ,Tetraselmis suecica ,Chlorella ,chemistry ,Biochemistry ,Chemistry (miscellaneous) ,Peptide ,Molecular Medicine ,Antimicrobial ,Oscillatoriales ,Antibacterial activity ,Bacteria ,Antimicrobial Cationic Peptides - Abstract
© 2020 by the authors., Cyanobacteria and microalgae are oxygen-producing photosynthetic unicellular organisms encompassing a great diversity of species, which are able to grow under all types of extreme environments and exposed to a wide variety of predators and microbial pathogens. The antibacterial compounds described for these organisms include alkaloids, fatty acids, indoles, macrolides, peptides, phenols, pigments and terpenes, among others. This review presents an overview of antibacterial peptides isolated from cyanobacteria and microalgae, as well as their synergism and mechanisms of action described so far. Antibacterial cyanopeptides belong to different orders, but mainly from Oscillatoriales and Nostocales. Cyanopeptides have different structures but are mainly cyclic peptides. This vast peptide repertoire includes ribosomal and abundant non-ribosomal peptides, evaluated by standard conventional methodologies against pathogenic Gram-negative and Gram-positive bacteria. The antibacterial activity described for microalgal peptides is considerably scarcer, and limited to protein hydrolysates from two Chlorella species, and few peptides from Tetraselmis suecica. Despite the promising applications of antibacterial peptides and the importance of searching for new natural sources of antibiotics, limitations still persist for their pharmaceutical applications., This research was funded by FONDECYT 1170379. LR was supported by a grant (RICET RD16/0027/0010) from the Subdirección General de Redes y Centros de Investigación Cooperativa-FEDER.
- Published
- 2020